NTLA logo

Intellia Therapeutics, Inc. (NTLA) Short term debt

Annual short term debt:

$20.25M+$1.65M(+8.86%)
December 31, 2024

Summary

  • As of today (July 27, 2025), NTLA annual short term debt is $20.25 million, with the most recent change of +$1.65 million (+8.86%) on December 31, 2024.
  • During the last 3 years, NTLA annual short term debt has risen by +$11.13 million (+122.19%).
  • NTLA annual short term debt is now at all-time high.

Performance

NTLA Short term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNTLAbalance sheet metrics

quarterly short term debt:

$38.76M+$18.52M(+91.46%)
March 31, 2025

Summary

  • As of today (July 27, 2025), NTLA quarterly short term debt is $38.76 million, with the most recent change of +$18.52 million (+91.46%) on March 31, 2025.
  • Over the past year, NTLA quarterly short term debt has increased by +$20.00 million (+106.59%).
  • NTLA quarterly short term debt is now at all-time high.

Performance

NTLA quarterly short term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNTLAbalance sheet metrics

Short term debt Formula

Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings

NTLA Short term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+8.9%+106.6%
3 y3 years+122.2%+315.1%
5 y5 years+252.4%+580.9%

NTLA Short term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+122.2%at high+305.1%
5 y5-yearat high+255.4%at high+580.5%
alltimeall timeat high>+9999.0%at high>+9999.0%

NTLA Short term debt History

DateAnnualQuarterly
Mar 2025
-
$38.76M(+91.5%)
Dec 2024
$20.25M(+8.9%)
$20.25M(+5.6%)
Sep 2024
-
$19.18M(+1.1%)
Jun 2024
-
$18.96M(+1.1%)
Mar 2024
-
$18.76M(+0.9%)
Dec 2023
$18.60M(+11.5%)
$18.60M(+8.9%)
Sep 2023
-
$17.07M(+1.9%)
Jun 2023
-
$16.75M(+2.6%)
Mar 2023
-
$16.33M(-2.1%)
Dec 2022
$16.68M(+83.1%)
$16.68M(+23.1%)
Sep 2022
-
$13.55M(+41.6%)
Jun 2022
-
$9.57M(+2.5%)
Mar 2022
-
$9.34M(+2.5%)
DateAnnualQuarterly
Dec 2021
$9.11M(+60.0%)
$9.11M(+4.7%)
Sep 2021
-
$8.71M(+17.4%)
Jun 2021
-
$7.42M(-10.2%)
Mar 2021
-
$8.26M(+44.9%)
Dec 2020
$5.70M(-0.9%)
$5.70M(-8.1%)
Sep 2020
-
$6.20M(+6.2%)
Jun 2020
-
$5.83M(+2.5%)
Mar 2020
-
$5.69M(-0.9%)
Dec 2019
$5.75M(>+9900.0%)
$5.75M(+4.4%)
Sep 2019
-
$5.50M(+8.7%)
Jun 2019
-
$5.07M(+15.6%)
Mar 2019
-
$4.38M(>+9900.0%)
Dec 2018
$0.00
$0.00

FAQ

  • What is Intellia Therapeutics, Inc. annual short term debt?
  • What is the all time high annual short term debt for Intellia Therapeutics, Inc.?
  • What is Intellia Therapeutics, Inc. annual short term debt year-on-year change?
  • What is Intellia Therapeutics, Inc. quarterly short term debt?
  • What is the all time high quarterly short term debt for Intellia Therapeutics, Inc.?
  • What is Intellia Therapeutics, Inc. quarterly short term debt year-on-year change?

What is Intellia Therapeutics, Inc. annual short term debt?

The current annual short term debt of NTLA is $20.25M

What is the all time high annual short term debt for Intellia Therapeutics, Inc.?

Intellia Therapeutics, Inc. all-time high annual short term debt is $20.25M

What is Intellia Therapeutics, Inc. annual short term debt year-on-year change?

Over the past year, NTLA annual short term debt has changed by +$1.65M (+8.86%)

What is Intellia Therapeutics, Inc. quarterly short term debt?

The current quarterly short term debt of NTLA is $38.76M

What is the all time high quarterly short term debt for Intellia Therapeutics, Inc.?

Intellia Therapeutics, Inc. all-time high quarterly short term debt is $38.76M

What is Intellia Therapeutics, Inc. quarterly short term debt year-on-year change?

Over the past year, NTLA quarterly short term debt has changed by +$20.00M (+106.59%)
On this page